MHC-II vs MHC-I Presentation

It’s important to tailor presentations to your target audience - even in the immune system. Different presentation mechanisms in APCs prioritize CD8 Killer T cells versus CD4 Helper T cells. In this #HCW episode, we illustrate how prioritizing presentation to CD8 Killer T cells leads to stronger anti-tumor effects.
Posted February 5, 2022 · Follow Us:
Share:

All Comics in the Oncology Series